Brief: Tenax Therapeutics Extends Us Regulatory Approval Deadline To December 31, 2035 Via Sixth Amendment To Orion License - SEC Filing
30/06/2026 22:31
BRIEF-Tenax Therapeutics Extends Us Regulatory Approval Deadline To December 31, 2035 Via Sixth Amendment To Orion License - SEC Filing June 30 (Reuters) - Tenax Therapeutics Inc TENX.O:
TENAX THERAPEUTICS: EXTENDS US REGULATORY APPROVAL DEADLINE TO DECEMBER 31, 2035 VIA SIXTH AMENDMENT TO ORION LICENSE - SEC FILING
Source text: [ID:n0001193125-26-290661]
Further company coverage: TENX.O
((Reuters.Briefs@thomsonreuters.com;))